Sponsor Pipeline

Madrigal Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
2
Recruiting
3
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-13 NCT07763015 Study of Resmetirom in Children and Adolescents With MASH Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
3
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04951219 A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients… Non-Alcoholic Fatty Liver Disease Active, Not Recruiting
NCT03900429 A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients… NASH - Nonalcoholic Steatohepatitis Active, Not Recruiting
NCT05500222 A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients… NASH Active, Not Recruiting
Phase 2
NCT07335601 Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH MASH - Metabolic Dysfunction-Associated Steatohepatitis Recruiting
NCT07763015 Study of Resmetirom in Children and Adolescents With MASH MASH Not Yet Recruiting
Not specified
NCT07541469 Rezdiffra Pregnancy and Lactation Registry MASH - Metabolic Dysfunction-Associated Steatohepatitis Recruiting
Disease Areas
NASH / MASH (5)
Get alerts when Madrigal Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free